IN BRIEF: Beximco s Private Market Covid Vaccine Supply Delayed
Thu, 4th Feb 2021 14:51
Beximco Pharmaceuticals Ltd - Bangladesh-based generic pharmaceutical products and active pharmaceutical ingredients maker - Partner Serum Institute of India Pvt Ltd s supply to Beximco of a first instalment of the Oxford University and AstraZeneca PLC Covid-19 vaccine for the Bangladesh private pay market has been delayed. The delay is attributed to prioritisation on supplying vaccine doses for government mass vaccination programmes as well as World Health Organisation-led initiatives over private pay use. The length of this delay, which is for the first 500,000 doses of a 1 million dose deal is not yet known, Beximco says.